
Leidos Hld (LDOS) Stock Forecast & Price Target
Leidos Hld (LDOS) Analyst Ratings
Bulls say
Leidos Holdings Inc. has demonstrated strong financial performance, particularly in the Health & Civil segment, where increased exam volumes have driven margin improvements, indicating operational scale advantages. The company's national security revenues experienced an 8% year-over-year increase, reaching $2.02 billion, supported by new contract awards and growth in defense IT and mission support services. Furthermore, the impressive growth of EBIT margins, rising from 14.5% in 2023 to 22.5% in 2024, and projected margins of 24.3% for the first half of 2025, underscore a robust operational efficiency and positive profitability trajectory.
Bears say
Leidos Holdings Inc. faces a negative outlook primarily driven by anticipated margin contractions in 2025, particularly in the second half of the year, which indicates decreased profitability compared to the first half. The company's managed health services segment is vulnerable to declines in medical exam volumes, further stressing margins and compounded by uncertainties surrounding defense spending and potential government budget cuts. Additionally, ongoing legal challenges related to large contract wins and risks associated with international operations add to the pressure on financial performance, potentially leading to a deterioration in investor sentiment.
This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.
Leidos Hld (LDOS) Analyst Forecast & Price Prediction
Start investing in Leidos Hld (LDOS)
Order type
Buy in
Order amount
Est. shares
0 shares